The research strongly establishes that bipolar disorder is real, highly heritable, and treatable, and that lithium prevents relapse and lowers suicide risk. What remains less settled is exactly how the biology works and where the softer edges of the bipolar spectrum should be drawn.
How bipolar disorder is studied
The evidence comes from several complementary lines of research, each answering a different kind of question.
Twin and family studies
Comparing identical and non-identical twins reveals how much of the risk is inherited, the basis for the high heritability estimates.
Genome-wide studies
Large-scale genetics identifies many small-effect risk variants, showing bipolar is polygenic and shares some genetic ground with other conditions.
Randomised trials
Controlled trials test whether treatments such as lithium and mood stabilisers actually prevent episodes, the basis for treatment guidelines.
Long-term cohorts
Following people over years maps the course of the illness, relapse patterns, and what predicts staying well.
What the evidence shows, graded honestly
Bipolar disorder is a real, valid, and highly heritable condition. Twin studies place heritability around 70 to 80 per cent, among the highest in psychiatry.
Lithium prevents relapse and is associated with a reduced risk of suicide. Its benefit for long-term stability is one of the best-supported findings in the field.
Maintenance treatment and stable routines, particularly protecting sleep, reduce how often and how severely episodes return.
The precise biology of mood episodes, and exactly how lithium works, are still being worked out. We know it helps far better than we know why.
Staging models, that bipolar may progress through phases, and efforts to predict who will respond to which treatment, are active but not yet settled.
Where to draw the boundaries of the bipolar spectrum, especially bipolar II and softer presentations, and whether the label is over or under-applied, remain genuinely debated.
The validity and frequency of bipolar disorder diagnosed in children is an area of ongoing disagreement between research and clinical traditions.
Two findings worth understanding in depth
Two results stand out both for how solid they are and for how much they shape care. They are worth a closer look than a single line.
Heritability, and what it does and does not mean
Bipolar disorder is one of the most heritable conditions in psychiatry, with twin studies converging on roughly 70 to 80 per cent. That figure is often misread. It does not mean an individual has a 70 per cent chance of developing bipolar if a parent has it, nor that the condition is purely genetic and unchangeable. Heritability is a population statistic describing how much of the variation in who develops the condition is explained by genetic differences. In practice it means genes load the dice heavily, but life still throws them: sleep disruption, stress, and other triggers help determine whether and when episodes actually occur in a vulnerable person. It is also polygenic, spread across many genes of small effect, which is why there is no single "bipolar gene" to test for.
Lithium: strong evidence, uncertain mechanism
Lithium is a striking example of a treatment whose benefits are far better understood than its workings. Decades of trials show it reduces relapse, and it is one of the very few treatments in medicine associated with a reduced risk of suicide. Yet exactly how a simple element stabilises mood at the molecular level is still being worked out. This gap matters for how you read claims: the fact that a mechanism is uncertain is not evidence that a treatment does not work, a distinction that applies across psychiatry. Lithium also illustrates why monitoring matters, since it requires regular blood tests to stay in a safe, effective range.
Reading bipolar claims critically
The pattern to hold in mind is that the core of bipolar disorder, that it is real, heritable, and responsive to treatment, is on very firm ground, while the edges, exact mechanisms and the softer diagnostic boundaries, are where the honest uncertainty lives. Confident headlines about a single "bipolar gene" or a clean brain-scan diagnosis run ahead of the evidence; the reliable story is polygenic risk, episodic illness, and treatments that work even where the mechanisms are incompletely understood.
Two habits help when reading about bipolar research. First, separate the strength of a claim from the confidence of its presentation: media coverage often flattens "an early study suggests" into "scientists discover". Second, watch for the mechanism-versus-effect confusion described above, it recurs constantly, and conflating the two is how genuinely helpful treatments get unfairly dismissed. The dependable throughline is that bipolar disorder is real and manageable, and that the people who do best are those who stay engaged with treatment through the well periods as well as the difficult ones.
Where to go next
Sources
- Craddock N, Sklar P. Genetics of bipolar disorder. The Lancet. 2013;381(9878):1654-1662.
- Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. The Lancet. 2013;381(9878):1672-1682.
- Cipriani A, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013;346:f3646.
This page is educational and summarises published research for general understanding. It is not medical advice and does not diagnose any condition. If you or someone you know is in immediate danger or having thoughts of suicide, contact your local emergency services or a suicide prevention helpline right away.